Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral CBD for Upper Extremity Musculoskeletal Pain
NCT06695195Phase 1Not yet recruiting
- Start
- Jun 2025
- Primary completion
- Mar 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of cannabidiol in Musculoskeletal pain. Planned start Jun 2025; status: not yet recruiting.
02
Drugs
cannabidiol
03
Conditions
Musculoskeletal pain
Beyond the preview
Go deeper on NCT06695195.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06695195.